ITGB2 and ovarian carcinoma: ITGB2 (CD18) is one of the key subunits of β2 integrin, and bioinformatic analysis revealed that ITGB2 expression was upregulated in high-risk groups and significantly correlated with the overall survival time in ovarian cancer patients.